BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16078930)

  • 1. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
    Rodríguez L; Velasco B; García J; Martín-Henao GA
    Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
    Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
    Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new automated cell washer device for thawed cord blood units.
    Perotti CG; Del Fante C; Viarengo G; Papa P; Rocchi L; Bergamaschi P; Bellotti L; Marchesi A; Salvaneschi L
    Transfusion; 2004 Jun; 44(6):900-6. PubMed ID: 15157258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
    Laroche V; McKenna DH; Moroff G; Schierman T; Kadidlo D; McCullough J
    Transfusion; 2005 Dec; 45(12):1909-16. PubMed ID: 16371043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
    Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
    Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
    Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
    Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
    Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
    Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
    Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
    Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
    Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
    Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
    Mfarrej B; Bouchet G; Couquiaud J; Regimbaud L; Binninger S; Mercier M; Lemarié C; Houzé P; Chabannon C; Calmels B
    Cytotherapy; 2017 Dec; 19(12):1501-1508. PubMed ID: 29037941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts.
    Decot V; Houzé P; Stoltz JF; Bensoussan D
    Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an automated closed fluid management device for processing expanded cytokine-induced killer cells to use in immunotherapy programs for cancer.
    Giancola R; Olioso P; Di Riti M; Capone A; Contento A; Pompetti F; Iacone A
    Transfusion; 2008 Apr; 48(4):629-39. PubMed ID: 18208417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
    Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø
    Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system.
    Rodríguez L; Azqueta C; Azzalin S; García J; Querol S
    Vox Sang; 2004 Oct; 87(3):165-72. PubMed ID: 15569068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.